(Allergan plc)

	AGN latest price $188.2069 (3.27%) ($182.7538 - $189.5678) on Fri. Nov. 4, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.7% (three month average)
RSI	27
Latest Price	$188.2069(3.27%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -1.8% a day on average for past five trading days.
Weekly Trend	AGN declines -6.7% a week on average for past two weeks.
Market Behavior	Normal for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(50%)    XBI(46%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -0.85% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-12%)    IPO(-6%)    SHY(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.85% (StdDev 1.7%)
Hourly BBV	0 ()
Intraday Trend	2.6%

Resistance Level	$212.66
5 Day Moving Average	$192.9(-2.43%)
10 Day Moving Average	$202.67(-7.14%)
20 Day Moving Average	$212.66(-11.5%)
To recent high	-23.2%
To recent low	3.3%
Market Cap	$62.052b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed